Intra-day Stock Recommendation [-]
Script Name Time Call No Buy/Sell Enter Between 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [26-07-2021 to 30-07-2021] Don't Tread
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
AXISBANK W-1 Buy 755 768 785++ 748 - SL HIT
LT W-2 Buy 1611 1635 1649++ 1600 - SL HIT
TATAMOTOR W-3 Buy 295 305 310++ 290 - SL HIT
DRREDDY W-4 Buy 5422 5554 5630++ 5400 - SL HIT
INDUSINDBK W-5 Buy 989 1040 1060++ 976 - SL HIT
MGL W-6 Buy 1144 1176 1196++ 1130 - SL HIT
Mainline IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Windlas Biotech Limited IPO Details 04-08-2020 06-08-2020 ₹ 401.54 Cr ₹ 448 - ₹ 460 30 ₹ 13,800 -
Rolex Rings Limited IPO Details 28-07-2020 30-07-2020 ₹ 700 Cr ₹ 960 - 970 15 ₹ 14,550 -
Glenmark Life Sciences Limited IPO Details 27-07-2020 29-07-2020 ₹ 1513.60 Cr ₹ 695-720 20 ₹ 14,400 -
Tatva Chintan Pharma Chem Limited IPO Details 16-07-2021 20-07-2021 ₹ 500 Cr ₹ 1073-1083 13 ₹ 14,079 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Network People Services Technologies Limited IPO Details 28-07-2020 02-08-2020 ₹ 13.70 Cr ₹ 76 - ₹ 80 1600 ₹ 1,28,000 -
Rex Pipes and Cables IPO Details 28-07-2020 02-08-2020 ₹ 6.24 Cr ₹ 26 4000 ₹ 1,04,000 -
Gretex Corporate Services Ltd IPO Details 27-07-2020 30-07-2020 ₹ 5.13 Cr ₹ 170 800 ₹ 1,36,000 -

Natco Pharma Limited Buy-Back Details

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has seven manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.

Natco family currently consists of more than 4000 employees, we are consistently ranked among fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in Pharmaceutical R&D..
Natco Pharma Limited Buy-Back Details
Date of Board Meeting for Buyback Proposal 05-11-2018
Date of Buyback Approval 05-11-2018
Date Public Announcement of Buyback 05-11-2018
Buyback Type Open Market
Buyback Record Date -
Buyback Opening Date 19-11-2018
Buyback Closing Date 18-05-2019
Buyback Amount ₹ 250 Cr
Buyback Number of Share -
Buyback Price ₹ 1000 Per Share
Face Value ₹ 2
Holding Time - Months
- -


Natco Pharma Limited Contact Details
NATCO Pharma Limited
Nalco House, Road No. 2, Banjara Hills,
Hyderabad, Telangana - 500 034.
Phone No. +91-40-2354 7532,
Website: www.natcopharma.co.in

0 Response to "Natco Pharma Limited Buy-Back Details"

Post a Comment